Vaccine's library 517 articles Export

	Cytotoxic T-lymphocyte responses to canarypox vector-based HIV vaccines in HIV-seronegative individuals: a meta-analysis of published studies. [My Copy] HIV Clin Trials, Vol. 5, No. 5. (t 2004), pp. 259-268. by S. Edupuganti, D. Weber, C. Poole posted to no-tag by Vaccine on 2006-03-27 16:38:48 as
	Pneumococcal conjugate vaccine: economic issues of the introduction of a new childhood vaccine. [My Copy] Expert Rev Vaccines, Vol. 1, No. 1. (June 2002), pp. 65-74. by G. T. Ray posted to no-tag by Vaccine on 2006-03-22 19:08:18 as
	AIDS Vaccine 2003. 18-21 September 2003, New York, NY, USA. [My Copy] IDrugs, Vol. 6, No. 11. (November 2003), pp. 1046-1048. by B. Korber posted to no-tag by Vaccine on 2006-03-21 14:45:08 as
	Immune responses and HIV: a little order from the chaos. [My Copy] J Exp Med (13 March 2006) by David H H. O'connor, Dennis R R. Burton posted to no-tag by Vaccine on 2006-03-16 17:45:10 as along with 1 person Natasha
	Lymphocyte subset reference ranges in adult Caucasians. [My Copy] Clin Immunol Immunopathol, Vol. 60, No. 2. (August 1991), pp. 190-208. by T. Reichert, M. DeBruyère, V. Deneys, et al.T. Tötterman, P. Lydyard, F. Yuksel, H. Chapel, D. Jewell, L. Van Hove, J. Linden posted to no-tag by Vaccine on 2006-03-08 16:25:53 as
	Antivector and antitransgene host responses in gene therapy. [My Copy] Curr Opin Mol Ther, Vol. 2, No. 4. (August 2000), pp. 376-382. by N. R. Hackett, S. M. Kaminsky, D. Sondhi, R. G. Crystal posted to no-tag by Vaccine on 2006-03-07 16:35:09 as
	Complement fixing antibodies to respiratory viruses in children in Jos, Nigeria. [My Copy] J Trop Pediatr, Vol. 41, No. 6. (December 1995), pp. 325-327. by G. Karaivanova, N. E. Gomwalk, I. Dobrev, H. O. Okunghae posted to no-tag by Vaccine on 2006-03-03 20:44:52 as
	The burden of pneumonia in children: an Asian perspective. [My Copy] Paediatr Respir Rev, Vol. 6, No. 2. (June 2005), pp. 88-93. by V. Singh posted to no-tag by Vaccine on 2006-03-03 20:40:04 as
	The rational design of an AIDS vaccine. [My Copy] Cell, Vol. 124, No. 4. (24 February 2006), pp. 677-681. by D. C. Douek, P. D. Kwong, G. J. Nabel posted to no-tag by Vaccine on 2006-03-02 20:26:50 as along with 2 people honglan lyndallsarkies
	Simian Immunodeficiency Virus Engrafted with Human Immunodeficiency Virus Type 1 (HIV-1)-Specific Epitopes: Replication, Neutralization, and Survey of HIV-1-Positive Plasma. [My Copy] J Virol, Vol. 80, No. 6. (March 2006), pp. 3030-3041. by E. Yuste, H. B. Sanford, J. Carmody, et al.J. Bixby, S. Little, M. B. Zwick, T. Greenough, D. R. Burton, D. D. Richman, R. C. Desrosiers, W. E. Johnson posted to no-tag by Vaccine on 2006-03-02 20:23:07 as
	Intranasal Sendai virus vaccine protects African green monkeys from infection with human parainfluenza virus-type one. [My Copy] Vaccine, Vol. 15, No. 5. (April 1997), pp. 533-540. by J. L. Hurwitz, K. F. Soike, M. Y. Sangster, et al.A. Portner, R. E. Sealy, D. H. Dawson, C. Coleclough posted to no-tag by Vaccine on 2006-02-28 15:33:04 as
	A two-year respiratory virus survey in four villages in West Bengal, India. [My Copy] Am J Epidemiol, Vol. 92, No. 5. (November 1970), pp. 307-320. by W. Kloene, F. B. Bang, S. M. Chakraborty, et al.M. R. Cooper, H. Kulemann, K. V. Shah, M. Ota posted to no-tag by Vaccine on 2006-02-28 15:32:10 as
	The etiology of respiratory tract infections in a tropical country. [My Copy] Am J Epidemiol, Vol. 97, No. 1. (January 1973), pp. 34-43. by L. C. Olson, U. Lexomboon, P. Sithisarn, H. E. Noyes posted to no-tag by Vaccine on 2006-02-28 15:31:27 as
	Comparison of whole gene and whole virus scrambled antigen approaches for DNA prime and fowlpox virus boost HIV type 1 vaccine regimens in macaques. [My Copy] AIDS Res Hum Retroviruses, Vol. 21, No. 4. (April 2005), pp. 292-300. by J. Pamungkas, R. De Rose, D. Iskandriati, et al.R. Noviana, Y. Paramastri, C. J. Dale, M. Shoobridge, C. J. Medveczky, I. A. Ramshaw, S. Thomson, S. J. Kent posted to no-tag by Vaccine on 2006-02-27 17:44:14 as
	Provision of HIV treatment in HIV preventive vaccine trials: a developing country perspective. [My Copy] Soc Sci Med, Vol. 60, No. 6. (March 2005), pp. 1197-1208. by C. Slack, M. Stobie, C. Milford, et al.G. Lindegger, D. Wassenaar, A. Strode, C. Ijsselmuiden posted to no-tag by Vaccine on 2006-02-27 17:36:06 as
	Kinetics of expansion of SIV Gag-specific CD8+ T lymphocytes following challenge of vaccinated macaques. [My Copy] Virology, Vol. 333, No. 2. (15 March 2005), pp. 226-238. by U. M. Abdel-Motal, J. Gillis, K. Manson, et al.M. Wyand, D. Montefiori, K. Stefano-Cole, R. C. Montelaro, J. D. Altman, R. P. Johnson posted to no-tag by Vaccine on 2006-02-27 17:32:11 as
	Studies on the cross-clade and cross-species conservation of HIV-1 Gag-specific CD8 and CD4 T cell responses elicited by a clade B DNA/MVA vaccine in macaques. [My Copy] Virology, Vol. 334, No. 1. (30 March 2005), pp. 124-133. by R. R. Amara, S. Sharma, M. Patel, et al.J. M. Smith, L. Chennareddi, J. G. Herndon, H. L. Robinson posted to no-tag by Vaccine on 2006-02-27 17:25:45 as
	Expanded breadth of virus neutralization after immunization with a multiclade envelope HIV vaccine candidate. [My Copy] Vaccine, Vol. 23, No. 26. (16 May 2005), pp. 3434-3445. by B. K. Chakrabarti, X. Ling, Z. Y. Yang, et al.D. C. Montefiori, A. Panet, W. P. Kong, B. Welcher, M. K. Louder, J. R. Mascola, G. J. Nabel posted to no-tag by Vaccine on 2006-02-27 17:18:54 as
	Non-replicating viral vector-based AIDS vaccines: interplay between viral vectors and the immune system. [My Copy] Curr HIV Res, Vol. 3, No. 2. (April 2005), pp. 157-181. by S. L. Sauter, A. Rahman, G. Muralidhar posted to no-tag by Vaccine on 2006-02-27 16:51:01 as
	Efficacy of a SHIV 89.6 proviral DNA vaccine against mucosal SIVmac239 challenge. [My Copy] Vaccine, Vol. 23, No. 31. (1 July 2005), pp. 4036-4047. by M. Busch, K. Abel, J. Li, M. Piatak, J. D. Lifson, C. J. Miller posted to no-tag by Vaccine on 2006-02-27 16:37:55 as
	Predicting the Potential Public Health Impact of Disease-Modifying HIV Vaccines in South Africa: The Problem of Subtypes. [My Copy] Curr Drug Targets Infect Disord, Vol. 5, No. 2. (July 2005), pp. 179-192. by S. M. Blower, E. N. Bodine, K. Grovit-Ferbas posted to no-tag by Vaccine on 2006-02-27 16:24:42 as
	Motivations for Participating in an HIV Vaccine Efficacy Trial. [My Copy] J Acquir Immune Defic Syndr, Vol. 39, No. 3. (1 July 2005), pp. 359-364. by Grant Colfax, Susan Buchbinder, Goli Vamshidar, et al.Connie Celum, David McKirnan, Judith Neidig, Beryl Koblin, Marc Gurwith, Brad Bartholow posted to no-tag by Vaccine on 2006-02-27 16:21:13 as
	Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3. [My Copy] Vaccine, Vol. 23, No. 42. (10 October 2005), pp. 5009-5021. by S. J. Kent, C. J. Dale, C. Ranasinghe, et al.I. Stratov, R. De Rose, S. Chea, D. C. Montefiori, S. Thomson, I. A. Ramshaw, B. E. Coupar, D. B. Boyle, M. Law, K. M. Wilson, A. J. Ramsay posted to no-tag by Vaccine on 2006-02-27 16:18:07 as
	HIV vaccine acceptability among women at risk: perceived barriers and facilitators to future HIV vaccine uptake. [My Copy] AIDS Educ Prev, Vol. 17, No. 3. (June 2005), pp. 253-267. by E. T. Rudy, P. A. Newman, N. Duan, E. M. Kelly, K. J. Roberts, D. S. Seiden posted to no-tag by Vaccine on 2006-02-27 16:16:18 as
	Participant retention in clinical trials of candidate HIV vaccines. [My Copy] J Acquir Immune Defic Syndr, Vol. 39, No. 4. (1 August 2005), pp. 499-501. by G. de Bruyn, M. G. Hudgens, P. S. Sullivan, A. C. Duerr posted to no-tag by Vaccine on 2006-02-27 16:13:45 as
	HIV vaccine design and the neutralizing antibody problem. [My Copy] Nat Immunol, Vol. 5, No. 3. (March 2004), pp. 233-236. by D. R. Burton, R. C. Desrosiers, R. W. Doms, et al.W. C. Koff, P. D. Kwong, J. P. Moore, G. J. Nabel, J. Sodroski, I. A. Wilson, R. T. Wyatt posted to no-tag by Vaccine on 2006-02-27 16:13:26 as along with 2 people cpiscitelli magnusc
	Changes in Willingness to Participate in HIV Vaccine Trials Among HIV-Negative Injection Drug Users [My Copy] AIDS and Behavior, Vol. 9, No. 3. (September 2005), pp. 301-309. by Elizabeth Golub, Lisa Purvis, Marcella Sapun, et al.Mahboobeh Safaeian, Chris Beyrer, David Vlahov, Steffanie Strathdee posted to no-tag by Vaccine on 2006-02-27 15:51:55 as
	Multi-envelope HIV-1 vaccine devoid of SIV components controls disease in macaques challenged with heterologous pathogenic SHIV. [My Copy] Vaccine, Vol. 23, No. 46-47. (16 November 2005), pp. 5306-5320. by X. Zhan, L. N. Martin, K. S. Slobod, et al.C. Coleclough, T. D. Lockey, S. A. Brown, J. Stambas, M. Bonsignori, R. E. Sealy, J. L. Blanchard, J. L. Hurwitz posted to no-tag by Vaccine on 2006-02-27 15:50:01 as
	Issues related to gay and bisexual men's acceptance of a future AIDS vaccine [My Copy] International Journal of STD & AIDS, Vol. 16, No. 8. (August 2005), pp. 546-548. by Laura F. Salazar, David Holtgrave, Richard A. Crosby, Paula Frew, John L. Peterson posted to no-tag by Vaccine on 2006-02-27 15:39:28 as
	Studies using a viral challenge and CD8 T cell depletions on the roles of cellular and humoral immunity in the control of an SHIV-89.6P challenge in DNA/MVA-vaccinated macaques. [My Copy] Virology, Vol. 343, No. 2. (20 December 2005), pp. 246-255. by R. R. Amara, C. Ibegbu, F. Villinger, et al.D. C. Montefiori, S. Sharma, P. Nigam, Y. Xu, H. M. McClure, H. L. Robinson posted to no-tag by Vaccine on 2006-02-27 15:29:24 as
	Enrollment of racial/ethnic minorities in NIAID-funded networks of HIV vaccine trials in the United States, 1988 to 2002. [My Copy] Public Health Rep, Vol. 120, No. 5. (t 2005), pp. 543-548. by G. Djomand, J. Katzman, D. di Tommaso, et al.M. G. Hudgens, G. W. Counts, B. A. Koblin, P. S. Sullivan posted to no-tag by Vaccine on 2006-02-27 15:12:41 as
	Safety and immunogenicity of an HIV-1 recombinant canarypox vaccine in newborns and infants of HIV-1-infected women. [My Copy] J Infect Dis, Vol. 192, No. 12. (15 December 2005), pp. 2129-2133. by D. C. Johnson, E. J. McFarland, P. Muresan, et al.T. Fenton, J. McNamara, J. S. Read, E. Hawkins, P. L. Bouquin, S. G. Estep, G. D. Tomaras, C. A. Vincent, M. Rathore, A. J. Melvin, S. Gurunathan, J. Lambert posted to no-tag by Vaccine on 2006-02-27 15:09:19 as
	Antibody recognition of a carbohydrate epitope: a template for HIV vaccine design. [My Copy] Adv Exp Med Biol, Vol. 564 (2005), pp. 7-8. by C. Scanlan, D. Calarese, H. K. Lee, et al.O. Blixt, C. H. Wong, I. Wilson, D. Burton, R. Dwek, P. Rudd posted to no-tag by Vaccine on 2006-02-27 14:26:58 as
	Development of a candidate DNA/MVA HIV-1 subtype C vaccine for India. [My Copy] Vaccine (4 January 2006) by Sanjeev Kumar, Priya Aggarwal, Madhu Vajpayee, R M M. Pandey, Pradeep Seth posted to no-tag by Vaccine on 2006-02-24 15:25:06 as
	Comparative studies on mucosal and intravenous transmission of simian immunodeficiency virus (SIVsm): the kinetics of evolution to neutralization resistance are related to progression rate of disease. [My Copy] J Gen Virol, Vol. 87, No. Pt 3. (March 2006), pp. 595-606. by A. Laurén, R. Thorstensson, E. M. Fenyö posted to no-tag by Vaccine on 2006-02-21 20:21:33 as
	HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T-cells. [My Copy] Blood (7 February 2006) by Michael R R. Betts, Martha C C. Nason, Sadie M M. West, et al.Stephen C C. De Rosa, Stephen A A. Migueles, Jonathan Abraham, Michael M M. Lederman, Jose M M. Benito, Paul A A. Goepfert, Mark Connors, Mario Roederer, Richard A A. Koup posted to no-tag by Vaccine on 2006-02-21 20:19:18 as
	Effect of the administration of recombinant hirudin and/or tissue-plasminogen activator (t-PA) on endotoxin-induced disseminated intravascular coagulation model in rabbits. [My Copy] Br J Haematol, Vol. 105, No. 1. (April 1999), pp. 117-121. by M. C. Muñoz, R. Montes, J. Hermida, J. Orbe, J. A. Páramo, E. Rocha posted to no-tag by Vaccine on 2006-02-13 14:08:16 as
	The regulation of DNA vaccines. [My Copy] Curr Opin Biotechnol, Vol. 12, No. 3. (June 2001), pp. 299-303. by H. A. Smith, D. M. Klinman posted to no-tag by Vaccine on 2006-02-10 15:08:24 as
	DNA vaccines: development, standardization and regulation. [My Copy] Intervirology, Vol. 43, No. 4-6. (2000), pp. 331-338. by K. Cichutek posted to no-tag by Vaccine on 2006-02-10 15:03:23 as
	Receptor interactions involved in adenoviral-mediated gene delivery after systemic administration in non-human primates. [My Copy] Hum Gene Ther, Vol. 14, No. 17. (20 November 2003), pp. 1595-1604. by T. A. Smith, N. Idamakanti, J. Marshall-Neff, et al.M. L. Rollence, P. Wright, M. Kaloss, L. King, C. Mech, L. Dinges, W. O. Iverson, A. D. Sherer, J. E. Markovits, R. M. Lyons, M. Kaleko, S. C. Stevenson posted to no-tag by Vaccine on 2006-02-10 14:17:24 as
	The Global Impact of Scaling-Up HIV/AIDS Prevention Programs in Low- and Middle-Income Countries. [My Copy] Science (2 February 2006) by John Stover, Stefano Bertozzi, Juan-Pablo P. Gutierrez, et al.Neff Walker, Karen A A. Stanecki, Robert Greener, Eleanor Gouws, Catherine Hankins, Geoff P P. Garnett, Joshua A A. Salomon, J Ties T. Boerma, Paul De Lay, Peter D D. Ghys posted to no-tag by Vaccine on 2006-02-10 14:15:52 as
	Selecting stable molecular targets for treatment and prevention of AIDS. [My Copy] Genome Inform Ser Workshop Genome Inform, Vol. 16, No. 1. (2005), pp. 254-261. by Y. E. Wang, C. Zhang, J. Berzofsky, C. DeLisi posted to no-tag by Vaccine on 2006-02-08 18:18:28 as
	Premature Induction of an Immunosuppressive Regulatory T Cell Response during Acute Simian Immunodeficiency Virus Infection. [My Copy] J Infect Dis, Vol. 193, No. 5. (1 March 2006), pp. 703-712. by J. D. Estes, Q. Li, M. R. Reynolds, et al.S. Wietgrefe, L. Duan, T. Schacker, L. J. Picker, D. I. Watkins, J. D. Lifson, C. Reilly, J. Carlis, A. T. Haase posted to no-tag by Vaccine on 2006-02-08 16:57:22 as
	HIV-1 receptors and cell tropism. [My Copy] Br Med Bull, Vol. 58 (2001), pp. 43-59. by P. R. Clapham, A. McKnight posted to no-tag by Vaccine on 2006-02-07 15:21:45 as along with 1 person lyndallsarkies
	Long-term CD8+ T cell memory to Sendai virus elicited by DNA vaccination. [My Copy] J Gen Virol, Vol. 80 ( Pt 6) (June 1999), pp. 1393-1399. by Y. Chen, E. J. Usherwood, S. L. Surman, T. L. Hogg, D. L. Woodland posted to no-tag by Vaccine on 2006-02-07 15:00:50 as
	CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients. [My Copy] Clin Infect Dis, Vol. 42, No. 5. (1 March 2006), pp. 709-715. by C. Goujard, M. Bonarek, L. Meyer, et al.F. Bonnet, M. L. Chaix, C. Deveau, M. Sinet, J. Galimand, J. F. Delfraissy, A. Venet, C. Rouzioux, P. Morlat, posted to no-tag by Vaccine on 2006-02-03 20:03:17 as
	Injection drug use and HIV/AIDS transmission in China. [My Copy] Cell Res, Vol. 15, No. 11-12. (c 2005), pp. 865-869. by T. X. Chu, J. A. Levy posted to no-tag by Vaccine on 2006-01-26 21:28:34 as
	Rural-to-Urban Migrants and the HIV Epidemic in China. [My Copy] AIDS Behav (19 January 2006), pp. 1-10. by Yan Hong, Bonita Stanton, Xiaoming Li, et al.Hongmei Yang, Danhua Lin, Xiaoyi Fang, Jing Wang, Rong Mao posted to no-tag by Vaccine on 2006-01-26 21:04:41 as
	GP120: Target for Neutralizing HIV-1 Antibodies. [My Copy] Annu Rev Immunol (16 January 2006) by Ralph Pantophlet, Dennis R R. Burton posted to no-tag by Vaccine on 2006-01-25 17:03:12 as along with 1 person cpiscitelli
	Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN 1, CIN 2, and CIN 3) associated with infection by oncogenic human papillomavirus. [My Copy] Hum Gene Ther, Vol. 15, No. 5. (May 2004), pp. 421-431. by C. M. Corona Gutierrez, A. Tinoco, T. Navarro, et al.M. L. Contreras, R. R. Cortes, P. Calzado, L. Reyes, R. Posternak, G. Morosoli, M. L. Verde, R. Rosales posted to no-tag by Vaccine on 2006-01-25 14:35:03 as

Note: You may cite this page as: http://www.citeulike.org/user/Vaccine

Result page: 1 2 3 4 5 6 7 8 9 10 Next

aids_vaccine_design	50
cellular_immune_response	49
transmission	44
viral_vectors	43
neutralizing_antibodies	33
clinical_trials	26
epidemiology	24
aids_disease_progression	24
other_vaccines	16
aids_vaccine_reviews_letters	15
diagnosis_testing	15
other_viral_vectors	13
health_policy	12
vaccine_design	9
in_process	9
risk_assessment	8
regulatory	7
antivirals	7
ethics_social_aspects	7
sendai	6
immunity	6
mucosal_immunity	4
other	4
hepatitis_c	4
vaccine_reviews	4
hiv_chemistry	3
ccr5	3
social_aspects	3
hiv_transmission	2
viral_load	2
hiv_other_clinical	2
ais_iavi_abstracts	1
virus	1

Vaccine's library 517 articles Export

Vaccine's tags